The State of the Industry
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
While that motive may be well-intentioned, it's not a good source of medical information. Just as with drug research, drug companies don't publish raw research data; they put it into a meaningful format, edit it, review it and spend a lot of money to do so. Plus, this research needs to be peer-reviewed and evaluated by experts in the field. Publishers are the ones that provide these services, and until it goes through that vetting system, it's not given credence to be published. All this costs money—money that is supplied by the medical publisher.
« Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 AllNext »
0 Comments
View Comments
Related Content
Comments